Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Loggie

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancer Letters|January 24, 2006
COX-2 expression in pseudomyxoma peritoneiZoran Gatalica, Brian Loggie
Annals of Surgical Oncology|November 8, 2015
Malignant Peritoneal Mesothelioma: Characterization of the Inflammatory Response in the Tumor MicroenvironmentSean Judge, Peter Thomas, Venkatesh Govindarajan, et al.
The Journal of Surgical Research|December 4, 2012
Kras mutations and p53 overexpression in pseudomyxoma peritonei: association with phenotype and prognosisShreya Shetty, Peter Thomas, Bala Ramanan, et al.
The American Surgeon|October 30, 2013
Proposed classification of pseudomyxoma peritonei: influence of signet ring cells on survivalShreya Shetty, Bala Natarajan, Peter Thomas, et al.
Annals of Surgical Oncology|September 19, 2013
Pseudomyxoma peritonei: inflammatory responses in the peritoneal microenvironmentKush Lohani, Shreya Shetty, Poonam Sharma, et al.
World Journal of Surgical Oncology|September 14, 2016
Early identification of DPAM in at-risk low-grade appendiceal mucinous neoplasm patients: a new approach to surveillance for peritoneal metastasisJason M Foster, Richard L Sleightholm, Steve Wahlmeier, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancer Letters|January 24, 2006
COX-2 expression in pseudomyxoma peritoneiZoran Gatalica, Brian Loggie
Annals of Surgical Oncology|November 8, 2015
Malignant Peritoneal Mesothelioma: Characterization of the Inflammatory Response in the Tumor MicroenvironmentSean Judge, Peter Thomas, Venkatesh Govindarajan, et al.
The Journal of Surgical Research|December 4, 2012
Kras mutations and p53 overexpression in pseudomyxoma peritonei: association with phenotype and prognosisShreya Shetty, Peter Thomas, Bala Ramanan, et al.
The American Surgeon|October 30, 2013
Proposed classification of pseudomyxoma peritonei: influence of signet ring cells on survivalShreya Shetty, Bala Natarajan, Peter Thomas, et al.
Annals of Surgical Oncology|September 19, 2013
Pseudomyxoma peritonei: inflammatory responses in the peritoneal microenvironmentKush Lohani, Shreya Shetty, Poonam Sharma, et al.
World Journal of Surgical Oncology|September 14, 2016
Early identification of DPAM in at-risk low-grade appendiceal mucinous neoplasm patients: a new approach to surveillance for peritoneal metastasisJason M Foster, Richard L Sleightholm, Steve Wahlmeier, et al.
Pageof 1